首页|阴道用乳杆菌活菌胶囊联合抗菌治疗对细菌性阴道病患者阴道微生态及复发的影响

阴道用乳杆菌活菌胶囊联合抗菌治疗对细菌性阴道病患者阴道微生态及复发的影响

扫码查看
目的:探讨阴道用乳杆菌活菌胶囊联合抗菌治疗对细菌性阴道病(BV)患者阴道微生态及复发的影响.方法:选取 2021 年 3 月—2023 年 3 月在抚州市妇幼保健所妇保科确诊的 105 例BV患者,采用简单随机分组法划分为两组,观察组(52 例)和对照组(53 例).对照组患者采用常规抗菌药物治疗,观察组患者在对照组的基础上给予阴道用乳杆菌活菌胶囊治疗.比较两组治疗过程中BV患者症状缓解情况及治疗后阴道微生态环境、炎症反应、疗效及复发的差异.结果:治疗后,两组患者pH值、菌群密集度、阴道清洁度评分均较治疗前下降,且观察组均低于对照组(P<0.05);治疗后两组乳酸杆菌数量评分均较治疗前上升,且观察组高于对照组(P<0.05).观察组症状缓解时间均比对照组早(P<0.05).治疗后,两组炎症因子水平均较治疗前下降,且观察组均低于对照组(P<0.05).观察组总有效率为 96.2%(50/52),高于对照组的 83.0%(44/53)(P<0.05).观察组复发率为 4.0%(2/50),低于对照组的 18.2%(8/44)(P<0.05).观察组不良反应发生率为 5.77%(3/52),对照组为 11.32%(6/53),差异无统计学意义(P>0.05).结论:阴道用乳杆菌活菌胶囊联合抗菌治疗可以有效改善BV患者阴道微生态环境,降低BV患者炎症因子水平,减少复发.
Effect of Live Lactobacillus Capsule for Vaginal Use Combined with Antibacterial Therapy on Vaginal Microecology and Recurrence in Patients with Bacterial Vaginosis
Objective:To investigate the effect of Live Lactobacillus Capsule for Vaginal Use combined with antibacterial therapy on vaginal microecology and recurrence in patients with bacterial vaginitis(BV).Method:A total of 105 BV patients diagnosed in the Maternal and Child Health Department of Fuzhou Maternal and Child Health Center from March 2021 to March 2023 were selected and divided into two groups by simple randomization method:observation group(52 cases)and control group(53 cases).The control group was treated with conventional antibiotics,and the observation group was treated with Live Lactobacillus Capsule for Vaginal Use on the basis of the control group.The differences of symptom remission during treatment,vaginal microecological environment,inflammatory response,efficacy and recurrence in BV patients were compared between the two groups.Result:After treatment,the pH,microflora density and vaginal cleanliness scores of both groups were lower than those before treatment,the observation group were lower than those of the control group(P<0.05).After treatment,the scores of lactobacillus number in both groups were higher than those before treatment,and the observation group was higher than that of the control group(P<0.05).Symptom remission time in observation group were earlier than those in control group(P<0.05).After treatment,the levels of inflammatory factors in both groups were lower than those before treatment,and the observation group were lower than those of the control group(P<0.05).The effective rate of the observation group was 96.2%(50/52),higher than 83.0%(44/53)of the control group(P<0.05).The recurrence rate of the observation group was 4.0%(2/48),lower than 18.2%(8/44)in the control group(P<0.05).The incidence of adverse reactions was 5.77%(3/52)in the observation group and 11.32%(6/53)in the control group,the difference was not statistically significant(P>0.05).Conclusion:Live Lactobacillus Capsule for Vaginal Use combined with antibacterial therapy can effectively improve vaginal microecological environment of patients with BV,lower the levels of inflammatory factors and reduce recurrence.

Bacterial vaginitisLive Lactobacillus Capsule for Vaginal UseAntibacterialVaginal microecology

曾芳

展开 >

抚州市妇幼保健所妇保科 江西 抚州 344000

细菌性阴道病 阴道用乳杆菌活菌胶囊 抗菌 阴道微生态

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(23)